JP2002513546A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002513546A5 JP2002513546A5 JP2000546798A JP2000546798A JP2002513546A5 JP 2002513546 A5 JP2002513546 A5 JP 2002513546A5 JP 2000546798 A JP2000546798 A JP 2000546798A JP 2000546798 A JP2000546798 A JP 2000546798A JP 2002513546 A5 JP2002513546 A5 JP 2002513546A5
- Authority
- JP
- Japan
- Prior art keywords
- polynucleotide
- hiv
- retroviral
- chiv
- chimeric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001177 retroviral effect Effects 0.000 description 12
- 239000002157 polynucleotide Substances 0.000 description 11
- 108091033319 polynucleotide Proteins 0.000 description 9
- 102000040430 polynucleotide Human genes 0.000 description 9
- 230000002163 immunogen Effects 0.000 description 8
- 239000002245 particle Substances 0.000 description 7
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 241001430294 unidentified retrovirus Species 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- 241000713756 Caprine arthritis encephalitis virus Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 108700004025 env Genes Proteins 0.000 description 3
- 101150030339 env gene Proteins 0.000 description 3
- 208000031886 HIV Infections Diseases 0.000 description 2
- 208000037357 HIV infectious disease Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 241000283707 Capra Species 0.000 description 1
- 108010070875 Human Immunodeficiency Virus tat Gene Products Proteins 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 108700004030 rev Genes Proteins 0.000 description 1
- 101150098213 rev gene Proteins 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8365298P | 1998-04-30 | 1998-04-30 | |
| US60/083,652 | 1998-04-30 | ||
| US09/302,171 US6602505B2 (en) | 1998-04-30 | 1999-04-29 | Viral chimeras comprised of CAEV and HIV-1 genetic elements |
| US09/302,171 | 1999-04-29 | ||
| PCT/US1999/006556 WO1999056774A1 (en) | 1998-04-30 | 1999-04-30 | Viral chimeras comprised of caev and hiv-1 genetic elements |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002513546A JP2002513546A (ja) | 2002-05-14 |
| JP2002513546A5 true JP2002513546A5 (enExample) | 2006-06-15 |
Family
ID=26769556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000546798A Pending JP2002513546A (ja) | 1998-04-30 | 1999-04-30 | Ｃａｅｖおよびｈｉｖ−１遺伝子エレメントから構成されるウイルスキメラ |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6602505B2 (enExample) |
| EP (1) | EP1073461B1 (enExample) |
| JP (1) | JP2002513546A (enExample) |
| KR (1) | KR20010074495A (enExample) |
| CN (1) | CN100346827C (enExample) |
| AT (1) | ATE284709T1 (enExample) |
| AU (1) | AU766264B2 (enExample) |
| CA (1) | CA2330618C (enExample) |
| DE (1) | DE69922642T2 (enExample) |
| IL (2) | IL139360A0 (enExample) |
| NZ (1) | NZ507942A (enExample) |
| WO (1) | WO1999056774A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6361784B1 (en) * | 2000-09-29 | 2002-03-26 | The Procter & Gamble Company | Soft, flexible disposable wipe with embossing |
| FR2979919B1 (fr) * | 2011-09-12 | 2015-12-11 | Centre Nat Rech Scient | Genomes lentiviraux chimeriques non-integratifs comme vaccins innovants contre vih-1 |
| WO2013126469A1 (en) * | 2012-02-21 | 2013-08-29 | Immunogenetix Therapeutics, Inc. | Chimeric dna vaccine compositions and methods of use |
| BR112017013574A2 (pt) * | 2014-12-23 | 2018-03-06 | Verdon Daniel | conjugados de aminoácido e peptídeo e usos dos mesmos |
| TW201735952A (zh) | 2016-02-26 | 2017-10-16 | 瑪格蕾特 安 布萊博 | 胺基酸及肽共軛物以及共軛過程 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5142025A (en) | 1986-08-01 | 1992-08-25 | Repligen Corporation | Recombinant HTLV-III proteins and uses thereof |
| US5256767A (en) | 1987-06-10 | 1993-10-26 | The Immune Response Corporation | Retroviral antigens |
| US5716826A (en) | 1988-03-21 | 1998-02-10 | Chiron Viagene, Inc. | Recombinant retroviruses |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5851813A (en) | 1990-07-12 | 1998-12-22 | President And Fellows Of Harvard College | Primate lentivirus antigenic compositions |
| US5714374A (en) | 1990-09-12 | 1998-02-03 | Rutgers University | Chimeric rhinoviruses |
| US5770428A (en) | 1993-02-17 | 1998-06-23 | Wisconsin Alumni Research Foundation | Chimeric retrovial expression vectors and particles containing a simple retroviral long terminal repeat, BLV or HIV coding regions and cis-acting regulatory sequences, and an RNA translational enhancer with internal ribsome entry site |
| US5561064A (en) | 1994-02-01 | 1996-10-01 | Vical Incorporated | Production of pharmaceutical-grade plasmid DNA |
| FR2721618B1 (fr) | 1994-06-28 | 1996-09-13 | Centre Nat Rech Scient | Fragments d'acide nucléique et fragments peptidiques correspondants issus du génome du virus de l'arthrite et de l'encéphalite caprine (VAEC) et leurs applications. |
| US5955342A (en) | 1994-08-15 | 1999-09-21 | Connaught Laboratories Limited | Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region |
| FR2732346B1 (fr) | 1995-03-27 | 1997-05-30 | Centre Nat Rech Scient | Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications |
| US5770357A (en) | 1996-03-15 | 1998-06-23 | Univ Southern California | Method of diagnosing caprine arthritis-encephalitis virus infection |
| RU2194529C2 (ru) | 1996-03-15 | 2002-12-20 | Юниверсити Оф Саузерн Калифорниа | Вирус козьего артрита-энцефалита, обеспечивающий иммунную защиту от инфекции вич-1 |
| EP1012236A1 (en) * | 1997-08-15 | 2000-06-28 | Rubicon Laboratory Inc. | Retrovirus and viral vectors |
-
1999
- 1999-04-29 US US09/302,171 patent/US6602505B2/en not_active Expired - Lifetime
- 1999-04-30 AU AU37406/99A patent/AU766264B2/en not_active Ceased
- 1999-04-30 CA CA2330618A patent/CA2330618C/en not_active Expired - Fee Related
- 1999-04-30 WO PCT/US1999/006556 patent/WO1999056774A1/en not_active Ceased
- 1999-04-30 CN CNB99807912XA patent/CN100346827C/zh not_active Expired - Fee Related
- 1999-04-30 AT AT99919756T patent/ATE284709T1/de not_active IP Right Cessation
- 1999-04-30 NZ NZ507942A patent/NZ507942A/xx not_active IP Right Cessation
- 1999-04-30 DE DE69922642T patent/DE69922642T2/de not_active Expired - Lifetime
- 1999-04-30 EP EP99919756A patent/EP1073461B1/en not_active Expired - Lifetime
- 1999-04-30 JP JP2000546798A patent/JP2002513546A/ja active Pending
- 1999-04-30 IL IL13936099A patent/IL139360A0/xx active IP Right Grant
- 1999-04-30 KR KR1020007012062A patent/KR20010074495A/ko not_active Withdrawn
-
2000
- 2000-10-30 IL IL139360A patent/IL139360A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5665577A (en) | Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof | |
| McTaggart et al. | Retroviral vectors for human gene delivery | |
| Dubay et al. | Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity | |
| JP3140757B2 (ja) | パッケージング欠陥ｈｉｖプロウイルス、細胞系及びその使用 | |
| US5763268A (en) | Hepatitis delta virus compositions and expression vectors | |
| AU641211B2 (en) | Vaccines | |
| Morikawa et al. | Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly | |
| AU3762889A (en) | Hiv-3 retrovirus and its use | |
| US6037172A (en) | Retroviral vector, a replication system for said vector and avian or mammalian cells transfected with said vector | |
| McGettigan et al. | Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector | |
| Berthoux et al. | Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis | |
| McGettigan et al. | Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome | |
| Böhnlein et al. | Identification of a U5-specific sequence required for efficient polyadenylation within the human immunodeficiency virus long terminal repeat | |
| DE69435316D1 (de) | Verfahren zur herstellung von hohen virustitern und die hocheffiziente transduktion von säugerzellen durch retroviren | |
| KR940019314A (ko) | 인체면역결핍 바이어스(hiv) 억제 안티센스 서열 및 그밖의 다른 뉴클레오타이드 서열을 함유하는 발현 작제물, 레트로바이러스성 벡터 및 이를 함유하는 재조합 레트로바이러스 | |
| Green et al. | Molecular features of the human T-cell leukemia virus: mechanisms of transformation and leukemogenicity | |
| Goepfert et al. | An endoplasmic reticulum retrieval signal partitions human foamy virus maturation to intracytoplasmic membranes | |
| JP3264281B2 (ja) | Ｈｉｖパッケージング配列を含むベクター、パッケージング不全ｈｉｖベクター及びその使用 | |
| CN116554349A (zh) | 嵌合病毒包膜糖蛋白及包含其的载体 | |
| Brody et al. | Mutations within the env gene of Mason-Pfizer monkey virus: effects on protein transport and SU-TM association | |
| JP2002513546A5 (enExample) | ||
| Ohsugi et al. | Construction of a full-length human T cell leukemia virus type I genome from MT-2 cells containing multiple defective proviruses using overlapping polymerase chain reaction | |
| CA2330618A1 (en) | Viral chimeras comprised of caev and hiv-1 genetic elements | |
| JP4178029B2 (ja) | Ｈｉｖ様粒子及びその用途 | |
| JP2003517839A5 (enExample) |